1. Home
  2. VS vs WINT Comparison

VS vs WINT Comparison

Compare VS & WINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VS
  • WINT
  • Stock Information
  • Founded
  • VS 2013
  • WINT 1992
  • Country
  • VS Canada
  • WINT United States
  • Employees
  • VS N/A
  • WINT N/A
  • Industry
  • VS EDP Services
  • WINT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • VS Technology
  • WINT Health Care
  • Exchange
  • VS Nasdaq
  • WINT Nasdaq
  • Market Cap
  • VS 5.0M
  • WINT 5.3M
  • IPO Year
  • VS N/A
  • WINT 1995
  • Fundamental
  • Price
  • VS $1.52
  • WINT $0.48
  • Analyst Decision
  • VS Hold
  • WINT Hold
  • Analyst Count
  • VS 1
  • WINT 1
  • Target Price
  • VS $3.00
  • WINT $18.00
  • AVG Volume (30 Days)
  • VS 121.2K
  • WINT 1.9M
  • Earning Date
  • VS 11-26-2024
  • WINT 11-26-2024
  • Dividend Yield
  • VS N/A
  • WINT N/A
  • EPS Growth
  • VS N/A
  • WINT N/A
  • EPS
  • VS N/A
  • WINT N/A
  • Revenue
  • VS $91,504.00
  • WINT N/A
  • Revenue This Year
  • VS N/A
  • WINT N/A
  • Revenue Next Year
  • VS $1,683.43
  • WINT N/A
  • P/E Ratio
  • VS N/A
  • WINT N/A
  • Revenue Growth
  • VS N/A
  • WINT N/A
  • 52 Week Low
  • VS $1.00
  • WINT $0.45
  • 52 Week High
  • VS $9.59
  • WINT $22.32
  • Technical
  • Relative Strength Index (RSI)
  • VS 39.53
  • WINT 24.83
  • Support Level
  • VS $1.51
  • WINT $0.53
  • Resistance Level
  • VS $2.03
  • WINT $0.64
  • Average True Range (ATR)
  • VS 0.16
  • WINT 0.07
  • MACD
  • VS -0.09
  • WINT 0.08
  • Stochastic Oscillator
  • VS 1.09
  • WINT 6.24

About VS Versus Systems Inc.

Versus Systems Inc offers a suite of proprietary business-to-business software tools that are meant to drive user engagement through gamification and rewards. These tools allow its partners to offer in-game prizes and rewards, including merchandise, coupons, digital goods, and sweepstakes entries - inside their websites, their venues, or their streaming media content. Its customers are mostly sports teams, venues, and advertising agencies, which typically use its products as part of their live events or as part of an advertising campaign with the goal of engaging fans, increasing consented first-party data, and increasing sales. The company operates in Canada and the USA.

About WINT Windtree Therapeutics Inc.

Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases. Its portfolio of product candidates includes istaroxime, a Phase 2 candidate with sarco endoplasmic reticulum Ca2+ -ATPase 2a, or SERCA2a, activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure, rostafuroxin for the treatment of hypertension in patients with a specific genetic profile, and a preclinical atypical protein kinase C iota, or aPKCi, inhibitor, being developed for potential application in rare and broad oncology indications. It operates in one operating segment, which is the research and development of products focused on cardiovascular disease.

Share on Social Networks: